AstraZeneca Initiates Global Recall of Covid-19 Vaccine, Withdraws Marketing Authorizations in Europe
AstraZeneca announced today that it has begun a worldwide recall of its Covid-19 vaccine, Vaxzevria, and will be withdrawing its marketing authorizations for the vaccine in Europe. The pharmaceutical company cited a “surplus of updated vaccines available” as the reason for the decision.
The recall comes after AstraZeneca admitted in court documents at the end of April that its Covid vaccine can cause thrombosis as a rare side effect. This admission, made during legal proceedings in London, has raised concerns about the safety of the vaccine and could lead to potential multimillion-dollar settlements, according to British media reports.
The Anglo-Swedish company’s decision to recall the vaccine and withdraw marketing authorizations in Europe marks a significant turn of events in the ongoing debate over the safety and efficacy of Covid-19 vaccines. AstraZeneca’s move may have far-reaching implications for the global vaccination effort and the public’s perception of vaccine safety.